Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Fc-mediated antibody effector functions during respiratory syncytial virus infection and disease
EA Van Erp, W Luytjes, G Ferwerda… - Frontiers in …, 2019 - frontiersin.org
Respiratory syncytial virus (RSV) is a major cause of severe lower respiratory tract infections
and hospitalization in infants under 1 year of age and there is currently no market-approved …
and hospitalization in infants under 1 year of age and there is currently no market-approved …
The immunoregulatory roles of antibody glycosylation
MF Jennewein, G Alter - Trends in immunology, 2017 - cell.com
Beyond their role in neutralization, antibodies mediate functions such as phagocytosis,
cytotoxicity, and maintenance of immune homeostasis. Two modifications to the constant …
cytotoxicity, and maintenance of immune homeostasis. Two modifications to the constant …
Natural killer cells in HIV-1 infection and therapy
J Mikulak, F Oriolo, E Zaghi, C Di Vito, D Mavilio - Aids, 2017 - journals.lww.com
Natural killer (NK) cells are important effectors of innate immunity playing a key role in the
eradication and clearance of viral infections. Over the recent years, several studies have …
eradication and clearance of viral infections. Over the recent years, several studies have …
NK cells in HIV disease
E Scully, G Alter - Current HIV/AIDS Reports, 2016 - Springer
Natural killer (NK) cells play a critical role in viral immunity. In the setting of HIV infection,
epidemiologic and functional evidence support a role for NK cells in both protection from …
epidemiologic and functional evidence support a role for NK cells in both protection from …
Influenza-specific antibody-dependent cellular cytotoxicity: toward a universal influenza vaccine
S Jegaskanda, PC Reading, SJ Kent - The Journal of Immunology, 2014 - journals.aai.org
There is an urgent need for universal influenza vaccines that can control emerging
pandemic influenza virus threats without the need to generate new vaccines for each strain …
pandemic influenza virus threats without the need to generate new vaccines for each strain …
Unraveling the dynamic mechanisms of natural killer cells in viral infections: insights and implications
Viruses pose a constant threat to human well-being, necessitating the immune system to
develop robust defenses. Natural killer (NK) cells, which play a crucial role in the immune …
develop robust defenses. Natural killer (NK) cells, which play a crucial role in the immune …
A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+ T Cells
Toll-like receptor (TLR) agonists are potent enhancers of innate antiviral immunity and may
also reverse HIV-1 latency. Therefore, TLR agonists have a potential role in the context of a …
also reverse HIV-1 latency. Therefore, TLR agonists have a potential role in the context of a …
HIV-1 Vpu antagonism of tetherin inhibits antibody-dependent cellular cytotoxic responses by natural killer cells
The type I interferon-inducible factor tetherin retains virus particles on the surfaces of cells
infected with vpu-deficient human immunodeficiency virus type 1 (HIV-1). While this …
infected with vpu-deficient human immunodeficiency virus type 1 (HIV-1). While this …
NK cell subsets and dysfunction during viral infection: a new avenue for therapeutics?
In the setting of viral challenge, natural killer (NK) cells play an important role as an early
immune responder against infection. During this response, significant changes in the NK cell …
immune responder against infection. During this response, significant changes in the NK cell …
Mind the gap: how interspecies variability in IgG and its receptors may complicate comparisons of human and non-human primate effector function
The field of HIV research relies heavily on non-human primates, particularly the members of
the macaque genus, as models for the evaluation of candidate vaccines and monoclonal …
the macaque genus, as models for the evaluation of candidate vaccines and monoclonal …